BENEVOLENTAI |
Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.676 EUR | +4.00% |
|
+0.90% | -37.41% |
| 15/04 | BenevolentAI S.A. Announces Board Resignations, Effective from May 2, 2024 | CI |
| 03/04 | BenevolentAI Founder Reportedly Calls for Board Revamp | MT |
Chart calendar BenevolentAI
947c.YxBdJHR7yy6CaZ1xqW9x8tcSnCDlR0Jm1o_UEKttwDk.GlYYYAwZlEXSDu897xY9sLYr-hmcMw8WhfWwRZo-tXBQVS9XEyuSdscOzA~7240b52f0cf29be3e81799890ec51cea
Upcoming events on BenevolentAI
Past events on BenevolentAI
| 14/03/2024 06:30 pm | Q4 2023 Earnings Call |
| 14/03/2024 11:30 am | Q4 2023 Earnings Release |
| 07/03/2024 | H.C. Wainwright Artificial Intelligence Based Drug Discovery & Development Virtual Conference - Fire |
| 11/01/2024 09:45 pm | JPMorgan Healthcare Conference |
| 21/09/2023 01:30 pm | Q2 2023 Earnings Call |
| 21/09/2023 10:31 am | Q2 2023 Earnings Release |
| 04/05/2023 05:30 pm | Annual General Meeting |
| 16/03/2023 03:00 pm | Q4 2022 Earnings Call |
| 16/03/2023 11:30 am | Q4 2022 Earnings Release |
| 09/03/2023 12:40 am | Cowen Health Care Conference |
| 19/01/2023 05:15 pm | World Economic Forum - Wellcome Trust Panel |
| 18/01/2023 08:45 pm | World Economic Forum - World Economic Forum Panel Session |
| 10/01/2023 03:45 am | J.P. Morgan Healthcare Conference |
| 17/11/2022 03:50 pm | Jefferies London Healthcare Conference |
| 27/09/2022 06:30 pm | Interim 2022 Earnings Call |
| 27/09/2022 | Interim 2022 Earnings Release |
| 13/06/2022 | Goldman Sachs Global Healthcare Conference |
Annual results
| Fiscal Period | December | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
|
Net sales Million GBP | Released Forecast Spread | 4,63 | 10,6 10,2 3.6% | 7,33 23,0 -68.13% | 33,6 |
|
EBITDA Million GBP | Released Forecast Spread | 0,00 | -91,5 -126 27.47% | -74,7 -80,0 6.63% | -28,8 |
|
EBIT Million GBP | Released Forecast Spread | 0,00 | -197 -118 -66.8% | -77,6 -64,0 -21.19% | -30,7 |
|
Earnings before Tax (EBT) Million GBP | Released Forecast Spread | 0,00 | 0,00 0,00 - | -72,7 -45,3 -60.45% | -34,0 |
|
Net income Million GBP | Released Forecast Spread | -86,5 | -164 -137 -19.34% | -63,3 -49,6 -27.57% | -6,11 |
|
EPS GBP | Released Forecast Spread | 0,00 | -1,50 -1,15 -30.87% | -0,54 -0,35 -55.01% | -0,03 |
| Announcement Date | 15/03/22 | 16/03/23 | 14/03/24 | - |
Quarterly results
| Fiscal Period | December | 2022 S2 | 2023 S1 | 2023 S2 | 2024 S1 | 2024 S2 |
|---|---|---|---|---|---|---|
|
Net sales Million GBP | Released Forecast Spread | 5,72 5,58 2.48% | 5,30 5,00 5.94% | 2,03 35,7 -94.3% | 8,00 | 56,0 |
|
EBITDA Million GBP | Released Forecast Spread | 41,5 49,0 -15.31% | ||||
|
EBIT Million GBP | Released Forecast Spread | -62,5 -49,8 -25.49% | -40,6 -38,0 -6.74% | -31,7 -2,17 -1363.91% | -24,8 | 20,7 |
|
EPS GBP | Released Forecast Spread | -0,31 -0,25 -23.66% | -0,22 0,05 -523.15% | -0,14 | 0,18 | |
| Announcement Date | 16/03/23 | 21/09/23 | 14/03/24 | - | - |
| Today 01:35 am | QIAGEN N.V.: Q1 2024 Earnings Release |
| 30/04/2024 | CRISPR THERAPEUTICS AG: Q1 2024 Earnings Release (Projected) |
| 01/05/2024 | DYNE THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected) |
| 01/05/2024 | PROTAGONIST THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected) |
| 01/05/2024 | EDITAS MEDICINE, INC.: Q1 2024 Earnings Release (Projected) |
| 01/05/2024 | AZENTA, INC.: Q2 2024 Earnings Release (Projected) |
| 01/05/2024 04:00 pm | UNITED THERAPEUTICS CORPORATION: Q1 2024 Earnings Release |
| 01/05/2024 04:00 pm | BIO-TECHNE CORPORATION: Q3 2024 Earnings Release |
| 01/05/2024 04:30 pm | ALKERMES PLC: Q1 2024 Earnings Release |
| 02/05/2024 | VIR BIOTECHNOLOGY, INC.: Q1 2024 Earnings Release |
Past sector events for BenevolentAI
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- BAI Stock
- Calendar BenevolentAI
